Drug Development & Clinical Trials - AstraZeneca and Daiichi Sankyo's cancer drug Enhertu improved outcomes for patients with early-stage breast cancer [1] Market Opportunity - The positive results could expand Enhertu's use to tens of thousands more people [1]